219 related articles for article (PubMed ID: 26881712)
1. Revisiting Non-Cancer Drugs for Cancer Therapy.
Yang EJ; Wu C; Liu Y; Lv J; Sup Shim J
Curr Top Med Chem; 2016; 16(19):2144-55. PubMed ID: 26881712
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity.
Viola-Rhenals M; Patel KR; Jaimes-Santamaria L; Wu G; Liu J; Dou QP
Curr Med Chem; 2018 Feb; 25(4):506-524. PubMed ID: 29065820
[TBL] [Abstract][Full Text] [Related]
3. Systems biology based drug repositioning for development of cancer therapy.
Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
[TBL] [Abstract][Full Text] [Related]
4. Computational drug repositioning for cancer therapeutics.
Jiao M; Liu G; Xue Y; Ding C
Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in drug repositioning for the discovery of new anticancer drugs.
Shim JS; Liu JO
Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
[TBL] [Abstract][Full Text] [Related]
6. Repurposing old drugs to fight multidrug resistant cancers.
Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
[TBL] [Abstract][Full Text] [Related]
7. Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth.
Yadav V; Talwar P
Biomed Pharmacother; 2019 Mar; 111():934-946. PubMed ID: 30841473
[TBL] [Abstract][Full Text] [Related]
8. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
Würth R; Thellung S; Bajetto A; Mazzanti M; Florio T; Barbieri F
Drug Discov Today; 2016 Jan; 21(1):190-199. PubMed ID: 26456577
[TBL] [Abstract][Full Text] [Related]
9. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing in Anticancer Reagent Development.
Chen PC; Liu X; Lin Y
Comb Chem High Throughput Screen; 2017; 20(5):395-402. PubMed ID: 28025934
[TBL] [Abstract][Full Text] [Related]
11. Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation.
Iwata M; Hirose L; Kohara H; Liao J; Sawada R; Akiyoshi S; Tani K; Yamanishi Y
J Med Chem; 2018 Nov; 61(21):9583-9595. PubMed ID: 30371064
[TBL] [Abstract][Full Text] [Related]
12. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
[TBL] [Abstract][Full Text] [Related]
13. Predicting new indications for approved drugs using a proteochemometric method.
Dakshanamurthy S; Issa NT; Assefnia S; Seshasayee A; Peters OJ; Madhavan S; Uren A; Brown ML; Byers SW
J Med Chem; 2012 Aug; 55(15):6832-48. PubMed ID: 22780961
[TBL] [Abstract][Full Text] [Related]
14. Drug repositioning in cancer: The current situation in Japan.
Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
[TBL] [Abstract][Full Text] [Related]
15. The novel role of pyrvinium in cancer therapy.
Momtazi-Borojeni AA; Abdollahi E; Ghasemi F; Caraglia M; Sahebkar A
J Cell Physiol; 2018 Apr; 233(4):2871-2881. PubMed ID: 28500633
[TBL] [Abstract][Full Text] [Related]
16. Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
Chen H; Wu J; Gao Y; Chen H; Zhou J
Curr Top Med Chem; 2016; 16(19):2107-14. PubMed ID: 26881709
[TBL] [Abstract][Full Text] [Related]
17. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
[TBL] [Abstract][Full Text] [Related]
18. Tumor deconstruction as a tool for advanced drug screening and repositioning.
Naik RR; Luo T; Kohandel M; Bapat SA
Pharmacol Res; 2016 Sep; 111():815-819. PubMed ID: 27431330
[TBL] [Abstract][Full Text] [Related]
19. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.
Skrott Z; Mistrik M; Andersen KK; Friis S; Majera D; Gursky J; Ozdian T; Bartkova J; Turi Z; Moudry P; Kraus M; Michalova M; Vaclavkova J; Dzubak P; Vrobel I; Pouckova P; Sedlacek J; Miklovicova A; Kutt A; Li J; Mattova J; Driessen C; Dou QP; Olsen J; Hajduch M; Cvek B; Deshaies RJ; Bartek J
Nature; 2017 Dec; 552(7684):194-199. PubMed ID: 29211715
[TBL] [Abstract][Full Text] [Related]
20. Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs.
Sohraby F; Aryapour H
Semin Cancer Biol; 2021 Jan; 68():249-257. PubMed ID: 32360530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
